FDA announced in March 2020, that due to the Covid-19 pandemic situation and the shortage of medical supplies, FDA USA will exempt the pre-market review
We use cookies to improve your user experience and for web traffic statistics purposes. By continuing to use this website, you agree to our use of cookies. Our Privacy Policy & Terms and Conditions contains more information on such use of cookies.